FDA NDC Directory · JSON-LD · Markdown

hydroxyzine pamoate

NDC 67296-0222 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerRedPharm Drug, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA086183
Dosage form / routeCAPSULE · ORAL
Active ingredientsHYDROXYZINE PAMOATE (50 mg/1)
Marketing started19811214
Marketing ended20260531
Package count2

External sources

Source: openFDA. Public-domain (CC0).